Skip to Main Content

Hired someone new and exciting? Promoting a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.

And here is our regular feature in which we highlight a different person each week. This time around, we note that Amgen (AMGN) hired Leah Christl as executive director of global regulatory and R&D policy. Previously, she worked at the Food and Drug Administration, where she was director for therapeutic biologics and biosimilars.


The FDA named Dr. Sarah Yim as acting director for therapeutic biologics and biosimilars;

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!